Company / Net Income
iSpecimen Inc. Net Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$12.5M
FY2025
5-year range
-$12.5M / -$4.7M
FY2021-FY2025
Trend
-12.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has declined for 4 consecutive years, from -$5M in FY2021 to -$12M in FY2025.
Based on SEC 10-K filings.
-$12M in FY2025.
Declined from -$10M to -$12M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- iSpecimen Inc.'s net income has declined for 4 consecutive years.
- In FY2025, net income decreased 12.6% year-over-year.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.90 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$12.5M | -12.6% |
| FY2024 | -$11.1M | -8.3% |
| FY2023 | -$10.2M | -14.3% |
| FY2022 | -$9.0M | -92.6% |
| FY2021 | -$4.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026